| Publications (3) |
Top | Institute | Publication |
| A1 Publications (3) [show] |
 Cooreman, K.; De Spiegeleer, B.; Van Poucke, C.; Vanavermaete, D.; Delbare, D.; Wynendaele, E.; De Witte, B. (2023). Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives. Environ. Toxicol. Pharmacol. 102: 104254. https://dx.doi.org/10.1016/j.etap.2023.104254, more- Janssens, Y.; Wynendaele, E.; Vanden Berghe, W.; De Spiegeleer, B. (2019). Peptides as epigenetic modulators: therapeutic implications. Clinical Epigenetics 11: 101. https://dx.doi.org/10.1186/s13148-019-0700-7, more
- Gevaert, B.; Veryser, L.; Verbeke, F.; Wynendaele, E.; De Spiegeleer, B. (2016). Fish hydrolysates: a regulatory perspective of bioactive peptides. Protein and Peptide Letters 23(12): 1052-1060. https://dx.doi.org/10.2174/0929866523666161102122637, more
|
|
